Filing Flows › Comparisons › TARS vs BCRX
Tarsus Pharmaceuticals vs Biocryst Pharmaceuticals: TARS and BCRX compared
Tarsus Pharmaceuticals is the larger company: $195M of revenue in its latest quarter (Q3 2026) against $180M for Biocryst Pharmaceuticals (Q3 2026). Tarsus Pharmaceuticals is growing faster (+64% against +13% a year earlier). Biocryst Pharmaceuticals is more profitable, with an operating margin of 29.6% against -340.3%.
Where the money goes: TARS and BCRX
Tarsus Pharmaceuticals (TARS) · Q3 2026
Tarsus Pharmaceuticals, Q3 2026: revenue $195M (+64% year over year), operating margin -340.3%, net loss $668M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Biocryst Pharmaceuticals (BCRX) · Q3 2026
Biocryst Pharmaceuticals, Q3 2026: revenue $180M (+13% year over year), operating margin 29.6%, net earnings $37.9M, operating cash flow $33.0M. The chart follows the revenue to costs, profit and cash.
| Tarsus Pharmaceuticals (TARS) | Biocryst Pharmaceuticals (BCRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $195M | $180M |
| Revenue growth, Y/Y | +64% | +13% |
| Operating margin | -340.3% | 29.6% |
| Net earnings | −$668M | $37.9M |
| Net margin | -343.5% | 21.0% |
| Operating cash flow | −$6.0M | $33.0M |
| Free cash flow | — | $32.8M |
Where the revenue comes from
Biocryst Pharmaceuticals
- Product: $172M (96%)
- License and other revenues: $8.0M (4%)
Questions
Which is bigger, Tarsus Pharmaceuticals or Biocryst Pharmaceuticals?
Tarsus Pharmaceuticals is the larger company: $195M of revenue in its latest quarter (Q3 2026) against $180M for Biocryst Pharmaceuticals (Q3 2026).
Is Tarsus Pharmaceuticals or Biocryst Pharmaceuticals growing faster?
Tarsus Pharmaceuticals is growing faster (+64% against +13% a year earlier).
Which is more profitable, Tarsus Pharmaceuticals or Biocryst Pharmaceuticals?
Biocryst Pharmaceuticals is more profitable, with an operating margin of 29.6% against -340.3%.
More: Tarsus Pharmaceuticals earnings · how Tarsus Pharmaceuticals makes money · Biocryst Pharmaceuticals earnings · how Biocryst Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.